SEC 13F Intelligence

THERAPIX BIOSCIENCES LTD

CUSIP 88339A203

Therapix Biosciences Ltd has 6 institutional holders in Filings Flow’s 13F database, together reporting 66.1K shares worth $41,000 as of Q2 2020. The largest reported holders are Ubs Group AG, A.r.t. Advisors, LLC, and Millennium Management LLC.

Institutional Holders
6
Q2 2020
Reported Value
$41,000
Ticker
unmapped
private placement or foreign
Quarters Tracked
6

Ownership Trend

Institutional holders
Q1 ’19: 3Q1 ’19Q2 ’19: 1Q2 ’19Q3 ’19: 2Q3 ’19Q4 ’19: 3Q4 ’19Q1 ’20: 3Q1 ’20Q2 ’20: 6Q2 ’20filingsflow.com
Total reported value
Q1 ’19: $223,000Q1 ’19Q2 ’19: $0Q2 ’19Q3 ’19: $1,000Q3 ’19Q4 ’19: $17,000Q4 ’19Q1 ’20: $6,000Q1 ’20Q2 ’20: $41,000Q2 ’20filingsflow.com

Holders

··Mixed quarters
Export to Excel
Manager% of PortfolioValueSharesQuarter
UBS Group AG$666.3B AUM0.00%$26,00041.4KQ2 2020
A.R.T. Advisors, LLC$2M AUM0.00%$15,00013.5KQ4 2019OLDER
MILLENNIUM MANAGEMENT LLC$240.3B AUM0.00%$9,00014.2KQ2 2020
ENVESTNET ASSET MANAGEMENT INC$373.6B AUM0.00%$6,00010.0KQ2 2020
CITADEL ADVISORS LLC$618.5B AUM0.00%$4,00010.2KQ1 2020OLDER
Private Capital Group, LLC$133M AUM—$0123Q2 2020
OSAIC HOLDINGS, INC.$68.3B AUM—$0302Q2 2020
CONCOURSE FINANCIAL GROUP SECURITIES, INC.$0 AUM—$00Q2 2020

Holdings are reported up to 45 days after quarter end. Share counts are as filed and not adjusted for stock splits.